Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
5.49
-0.19 (-3.35%)
At close: May 9, 2025, 4:00 PM
5.65
+0.16 (2.91%)
After-hours: May 9, 2025, 4:26 PM EDT
Apollomics Market Cap
Apollomics has a market cap or net worth of $6.06 million as of May 9, 2025. Its market cap has decreased by -85.75% in one year.
Market Cap
6.06M
Enterprise Value
-2.55M
1-Year Change
-85.75%
Ranking
Category
Stock Price
$5.49
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $6.06M, a decrease of -95.33%. That is a compound annual growth rate of -58.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2025 | 6.27M | -41.71% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 695.85B |
| Johnson & Johnson | 371.67B |
| UnitedHealth Group | 359.09B |
| AbbVie | 331.06B |
| Novo Nordisk | 297.73B |
| Abbott Laboratories | 231.50B |
| AstraZeneca | 221.83B |
| Novartis AG | 220.92B |